Glioblastoma
Maha & Baba: A Caregiver’s Journey Through Glioblastoma
My name is Maha, and I had the privilege of being my father’s — my Baba’s — caregiver. I’ll be blunt; it was tough. When
Awareness Isn’t the Hard Part — What 18 Years in the Moebius Syndrome Community Has Taught Me
- April 26, 2026
From Overlooked to Unstoppable: The Mendoza Story That Inspired a Nation
Choosing Hope
Ophthalmologist Emerges as Leading Candidate to Head FDA Vaccine Division
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Psoriasis
One-Year Data Reinforces Icotyde’s Position as Transformative Psoriasis Therapy: Sustained Clearance and Favorable Safety Profile
Johnson & Johnson announced promising long-term efficacy and safety data for Icotyde (icotrokinra), the first and only targeted oral peptide that precisely blocks the IL-23
Multiple Sclerosis
Roche’s Elecsys NfL Blood Test Gains CE Mark for Monitoring Neuroinflammation in MS
As reported on PharmaBiz, Roche has secured CE mark approval for its Elecsys Neurofilament Light Chain (NfL) assay, a blood-based test designed to help detect
Brain Cancer
Invading the Blood Brain Barrier: FDA Approves Pembrolizumab Combo
Astrocytoma and glioblastoma are fast-growing brain cancers that often return after surgery, with survival for astrocytoma patients averaging only four to five months. While medications
Atopic dermatitis
Lynk Pharmaceuticals Achieves Regulatory Milestone: Zemprocitinib Advances in China for Atopic Dermatitis Treatment
Lynk Pharmaceuticals announced a significant development in its pipeline with the China National Medical Products Administration (NMPA) formally accepting the New Drug Application (NDA) for
Cervical Dystonia
5 Lessons Nature Taught Me About Living with Pain and Dystonia
I’ve always been a nature lover. I like nothing better than going for a hike in the woods or strolling along the beach or gazing
Lymphoma
What We Carry With Us: The Lesson of the Quilt
Editor’s Note: Patient Worthy is honored to share this submission by Regina Portnoy, a clinical researcher with 20 years of experience working alongside patients. Many
Small cell lung cancer
Breakthrough Lung Cancer Therapy Advances: Ifinatamab Deruxtecan Receives FDA Priority Review for Small Cell Lung Cancer
Daiichi Sankyo and Merck announced a significant regulatory milestone with the FDA’s acceptance and Priority Review of ifinatamab deruxtecan (I-DXd), a potentially first-in-class therapeutic targeting
Duchenne Muscular Dystrophy
Roche to Launch New Elevidys Trial After European Rejection — What’s Going On?
As reported on BioPharmaDive, Roche is restarting efforts to get Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), approved in Europe by launching a
Breast Cancer
Katrina’s Journey with Metastatic Breast Cancer
I’ve always been an overachiever – someone who puts their mind to something and delivers more than was expected, someone who strives for greatness. I
Uveal melanoma
Darovasertib-Crizotinib Combination Achieves Breakthrough Efficacy in Metastatic Eye Cancer
IDEAYA Biosciences and Servier announced promising Phase 2/3 trial results for darovasertib, a selective PKC inhibitor, combined with crizotinib in the treatment of metastatic uveal
HIV/AIDS
Norway Case Adds Insight Into Long-Term HIV Remission After Stem Cell Transplant
As reported on Healthline, a man in Norway has entered sustained HIV remission following a stem cell transplant, becoming one of a small number of
Leukemia
Ziftomenib: FDA’s Newly Approved Lifeline for Leukemia Patients
Two University of Michigan professors, Jolanta Grembecka and her husband Tomasz Cierpicki, created the newly approved leukemia drug ziftomenib. Its recent FDA approval offers new
Duchenne Muscular Dystrophy
Sarepta Advances Precision Genetic Therapies Toward Full FDA Approval: AMONDYS 45 and VYONDYS 53 Seek Traditional Approval Status
Sarepta Therapeutics has announced a significant regulatory milestone in its efforts to secure permanent FDA approval for two breakthrough Duchenne muscular dystrophy (DMD) treatments. As
Rare Disease
Simple Daily Habits to Boost Your Whole-Body Health and Well-Being
Editor’s Note: Patient Worthy is honored to share this article, originally submitted by Camille Johnson. For chronic disease patients living with rare conditions and long-term
Amyloidosis
Extended Acoramidis Data Show Durable Survival Advantage in ATTR-CM
As reported on Cardiovascular Business, new long-term findings presented at the American College of Cardiology (ACC) 2026 meeting provide compelling evidence that early and continuous
Alzheimer's disease
New Study Reports How Individual Areas of the Brain Age
A pivotal study recently published in the journal Gero Science has revealed new insights into how individual brain regions age and why some are more
Spinal Muscular Atrophy
Optimized Dosing Delivers Enhanced Motor Benefits: FDA Approves High-Dose Spinraza Regimen for Spinal Muscular Atrophy
A decade of accumulated clinical experience with nusinersen has culminated in a significant regulatory advancement. According to Pharma Times Online, Biogen’s newly approved high-dose Spinraza
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Caring for Duchenne muscular dystrophy is about more than treatment- it's about adapting, supporting, and empowering every step of the journey. With the right combination of medical care, therapies, and daily support, individuals can maintain independence longer and improve overall quality of life. Awareness and understanding play a key role in ensuring those affected receive the comprehensive care they deserve. #dmdawareness #HealthcareEducation #PatientWorthy
We're honored to bring you this story-share from Tim, who discusses nearly two decades worth of experiences in the Moebius syndrome community. Read here:
patientworthy.com
Awareness Isn’t the Hard Part — What 18 Years in the Moebius Syndrome Community Has Taught Me Post author:Patient Worthy Contributor Post published:April 26, 2026 Post category:Moebius Syndrome Fo...
From Overlooked to Unstoppable: The Mendoza Story That Inspired a Nation bit.ly/4sYbEft Read now at PatientWorthy.com
#PatientWorthy #MultipleSclerosis #MS #football #NFLDraft
